Related Experiment Videos

Cardiovascular risk factors and HDL-cholesterol levels in obesity

Insights

Obese patients exhibit numerous cardiovascular risk factors, including hypertension and glucose intolerance. Low HDL-cholesterol and high insulin levels indicate a significant risk for cardiovascular disease development in this population.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Obesity is a growing global health concern.
  • Cardiovascular disease (CVD) risk factors are prevalent in obese individuals.
  • Understanding the interplay of obesity, metabolic markers, and CVD risk is crucial.

Purpose of the Study:

  • To investigate cardiovascular risk factors (RF), serum HDL-cholesterol, and insulin levels in a large cohort of obese patients.
  • To assess the relationship between obesity severity, age, and these metabolic parameters.
  • To determine the overall cardiovascular risk profile of obese individuals.

Main Methods:

  • Cross-sectional study of 1332 patients with varying degrees of obesity.
  • Assessment of common cardiovascular risk factors: hypertension, glucose intolerance, hypertriglyceridemia, hyperuricemia, hypercholesterolemia.
  • Measurement of serum HDL-cholesterol and insulin levels.
  • Statistical analysis including correlation and partial correlation.

Main Results:

  • The majority of obese patients (90.6%) presented with at least one cardiovascular RF.
  • Diastolic hypertension (68%) and systolic hypertension (56%) were the most frequent RFs.
  • Obese patients showed decreased HDL-cholesterol and elevated insulin levels, particularly women.
  • Age had a stronger influence than body weight on blood pressure and lipid/glucose levels, while body weight directly correlated with uric acid and inversely with HDL-cholesterol.

Conclusions:

  • Obese patients represent a high-risk group for cardiovascular disease development.
  • Prevalence of RFs, low HDL-cholesterol, and high insulin levels underscore the need for proactive management.
  • Targeted interventions addressing obesity and associated metabolic disturbances are essential for CVD prevention.

Related Concept Videos